Advanced Medical Solutions Group (LON:AMS) Receives Buy Rating from Berenberg Bank

Advanced Medical Solutions Group (LON:AMS)‘s stock had its “buy” rating restated by investment analysts at Berenberg Bank in a report released on Thursday,London Stock Exchange reports. They currently have a GBX 300 price objective on the stock. Berenberg Bank’s target price suggests a potential upside of 33.93% from the company’s current price.

Separately, Peel Hunt reissued a “buy” rating and set a GBX 246 target price on shares of Advanced Medical Solutions Group in a research report on Wednesday, September 17th. Three analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock has a consensus rating of “Buy” and an average price target of GBX 273.67.

Advanced Medical Solutions Group Stock Up 0.9%

Shares of AMS traded up GBX 2 during midday trading on Thursday, reaching GBX 224. 513,825 shares of the stock were exchanged, compared to its average volume of 499,411. The company has a market capitalization of £484.64 million, a P/E ratio of 53.72, a PEG ratio of 5.00 and a beta of 0.74. The company has a current ratio of 8.39, a quick ratio of 4.58 and a debt-to-equity ratio of 37.01. Advanced Medical Solutions Group has a 52 week low of GBX 168.40 and a 52 week high of GBX 248.50. The company’s 50 day moving average is GBX 214.89 and its two-hundred day moving average is GBX 212.36.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.